Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Mellonig

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The International Journal of Periodontics & Restorative Dentistry|January 25, 2007
Histologic and clinical evaluation of an allogeneic bone matrix for the treatment of periodontal osseous defectsJames T Mellonig
Journal of Periodontology|March 15, 2018
PRESIDENT'S ADDRESSJames T Mellonig
The International Journal of Periodontics & Restorative Dentistry|March 16, 2010
Clinical and histologic evaluation of calcium-phosphate bone cement in interproximal osseous defects in humans: a report in four patientsJames T Mellonig, Pilar Valderrama, David L Cochran
The International Journal of Periodontics & Restorative Dentistry|May 12, 2012
Histologic evaluation of an allogeneic mineralized bone matrix in the treatment of periodontal osseous defectsJana-Marie Koylass, Pilar Valderrama, James T Mellonig
The International Journal of Periodontics & Restorative Dentistry|February 28, 2009
Evaluation of a mineralized cancellous bone allograft for the treatment of periodontal osseous defects: 6-month surgical reentryEric S Browning, Brian L Mealey, James T Mellonig
Journal of Clinical Periodontology|July 31, 2003
Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapyMauricio A Gutierrez, James T Mellonig, David L Cochran
Journal of Periodontology|November 26, 2004
Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humansBrian S Gurinsky, Michael P Mills, James T Mellonig
Journal of Periodontology|May 7, 2002
Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humansDiega Velasquez-Plata, E Todd Scheyer, James T Mellonig
The International Journal of Periodontics & Restorative Dentistry|June 13, 2008
Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defectsHeather K Ridgway, James T Mellonig, David L Cochran
The International Journal of Periodontics & Restorative Dentistry|May 5, 2009
Histological and clinical evaluation of recombinant human platelet-derived growth factor combined with beta tricalcium phosphate for the treatment of human Class III furcation defectsJames T Mellonig, Maria del Pilar Valderrama, David L Cochran
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The International Journal of Periodontics & Restorative Dentistry|January 25, 2007
Histologic and clinical evaluation of an allogeneic bone matrix for the treatment of periodontal osseous defectsJames T Mellonig
Journal of Periodontology|March 15, 2018
PRESIDENT'S ADDRESSJames T Mellonig
The International Journal of Periodontics & Restorative Dentistry|March 16, 2010
Clinical and histologic evaluation of calcium-phosphate bone cement in interproximal osseous defects in humans: a report in four patientsJames T Mellonig, Pilar Valderrama, David L Cochran
The International Journal of Periodontics & Restorative Dentistry|May 12, 2012
Histologic evaluation of an allogeneic mineralized bone matrix in the treatment of periodontal osseous defectsJana-Marie Koylass, Pilar Valderrama, James T Mellonig
The International Journal of Periodontics & Restorative Dentistry|February 28, 2009
Evaluation of a mineralized cancellous bone allograft for the treatment of periodontal osseous defects: 6-month surgical reentryEric S Browning, Brian L Mealey, James T Mellonig
Journal of Clinical Periodontology|July 31, 2003
Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapyMauricio A Gutierrez, James T Mellonig, David L Cochran
Journal of Periodontology|November 26, 2004
Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humansBrian S Gurinsky, Michael P Mills, James T Mellonig
Journal of Periodontology|May 7, 2002
Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humansDiega Velasquez-Plata, E Todd Scheyer, James T Mellonig
The International Journal of Periodontics & Restorative Dentistry|June 13, 2008
Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defectsHeather K Ridgway, James T Mellonig, David L Cochran
The International Journal of Periodontics & Restorative Dentistry|May 5, 2009
Histological and clinical evaluation of recombinant human platelet-derived growth factor combined with beta tricalcium phosphate for the treatment of human Class III furcation defectsJames T Mellonig, Maria del Pilar Valderrama, David L Cochran
Pageof 4